CERO THERAPEUTICS HOLDINGS I (CERO) Stock Earnings & Estimates
USA - NASDAQ:CERO - US71902K4022 - Common Stock
0.0951 USD
-1.69 (-94.69%)
0.12 USD
+0.02 (+26.18%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 152.02% | N/A 119.07% | N/A 85.98% | |||||
| EBITDA YoY % growth | N/A | N/A | N/A | -15.76M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -332K | -2.905M -775.12% | -2.933M -0.95% | -16.198M -452.27% | N/A -12.42% | N/A -20.22% | N/A -64.23% | N/A -18.28% | N/A -5.00% | N/A -6.96% | N/A 26.70% | N/A 177.52% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 38.38% | N/A 1.01% | N/A 87.18% | N/A -1.45% | N/A 15.71% | N/A 89.83% | N/A 770.83% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -1.55 | -1.73 |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -4.585M -4.16% | -4.868M -132.33% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -28.80 | -121.58 | 92.78 | 76.31% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 83.22% | 83.22% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |